Register entry
Boehringer Ingelheim RCV GmbH & Co KG
- Registered sites
- 1
- Drug products
- 17
- Live patents
- 0
- Countries
- 1
- Base
- Austria
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Analytical testingActive ingredient (API) manufacture
Sites
Facilities
1| Site | Location | Operations | FEI |
|---|---|---|---|
| Boehringer Ingelheim RCV GmbH & Co KG | ViennaAustria | Analytical testing, Active ingredient (API) manufacture | 3003433722 |
Catalogue
Marketed products
17Showing 17 of 17.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| - | Aldesleukin | POWDER | DRUG FOR FURTHER PROCESSING |
| - | Alteplase | POWDER, FOR SOLUTION | BULK INGREDIENT |
| - | Anakinra | LIQUID | BULK INGREDIENT |
| - | Human Parathyroid Hormone | LIQUID | BULK INGREDIENT |
| - | Human papillomavirus type 11 L1 protein adsorbed | LIQUID | DRUG FOR FURTHER PROCESSING |
| - | Human papillomavirus type 16 L1 protein adsorbed | LIQUID | DRUG FOR FURTHER PROCESSING |
| - | Human papillomavirus type 18 L1 protein adsorbed | LIQUID | DRUG FOR FURTHER PROCESSING |
| - | Human papillomavirus type 6 L1 protein adsorbed | INJECTION, SOLUTION | BULK INGREDIENT |
| - | Interferon beta-1b | POWDER, FOR SOLUTION | BULK INGREDIENT |
| - | Interferon-gamma-1b | LIQUID | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | MnB rLP2086 subfamily A protein | SUSPENSION | DRUG FOR FURTHER PROCESSING |
| - | MnB rLP2086 subfamily B protein | SUSPENSION | DRUG FOR FURTHER PROCESSING |
| - | Pegvaliase | LIQUID | DRUG FOR FURTHER PROCESSING |
| - | Somatropin | INJECTION, SOLUTION | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Teduglutide | SOLUTION | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Teriparatide | INJECTION, SOLUTION | BULK INGREDIENT |
| - | Trastuzumab deruxtecan | POWDER, FOR SOLUTION | BULK INGREDIENT |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.